Pharmaceutical Pipeline

Our understanding of ACC’s potential allows us to leverage it for the treatment of hypoparathyroidism–a rare endocrine disorder characterized by dysfunction or decreased function of the parathyroid glands, which causes underproduction of parathyroid hormone (PTH).
Amorphical has managed to successfully synthesize and produce nanoparticulate amorphous calcium carbonate (ACC) having log-term stability. Amorphical’s ACC is the only non-crystalline calcium supplement in the world.

Increased solubility and Increased bioavailability
The safest anti-inflammatory substance that are available in the market.

Skip to content